SNN - Smith & Nephew: Work To Be Done But Still Long-Term Potential
2024-06-11 20:38:37 ET
Summary
- Smith & Nephew's share price has increased by 14% since September 2022, indicating undervaluation.
- The company showed decent topline growth with a 6.4% increase in revenue last year.
- While the company's growth plans are transforming the business, there are concerns about the actual performance and management quality.
Medical devices and supplies manufacturer Smith & Nephew (SNN) has had an underwhelming several years but at its core is a well-positioned business in a business area with premium pricing and long-term growth prospects....
Smith & Nephew: Work To Be Done But Still Long-Term Potential